Articles with public access mandates - Gilles J. Guillemin, AM, GAICDLearn more
Not available anywhere: 36
The kynurenine pathway and inflammation in amyotrophic lateral sclerosis
Y Chen, R Stankovic, KM Cullen, V Meininger, B Garner, S Coggan, ...
Neurotoxicity research 18, 132-142, 2010
Mandates: US National Institutes of Health
Involvement of the kynurenine pathway in the pathogenesis of Parkinson’s disease
CK Lim, FJ Fernandez-Gomez, N Braidy, C Estrada, C Costa, S Costa, ...
Progress in Neurobiology 155, 76-95, 2017
Mandates: Australian Research Council, National Health and Medical Research Council …
p38 MAPK inhibitors attenuate pro-inflammatory cytokine production and the invasiveness of human U251 glioblastoma cells
YT Yeung, NS Bryce, S Adams, N Braidy, M Konayagi, KL McDonald, ...
Journal of neuro-oncology 109, 35-44, 2012
Mandates: National Health and Medical Research Council, Australia
Phosphodiesterase-4 enzyme as a therapeutic target in neurological disorders
A Bhat, B Ray, AM Mahalakshmi, S Tuladhar, DN Nandakumar, ...
Pharmacological research 160, 105078, 2020
Mandates: National Health and Medical Research Council, Australia
BMAA and neurodegenerative illness
PA Cox, RM Kostrzewa, GJ Guillemin
Neurotoxicity research 33 (1), 178-183, 2018
Mandates: Australian Research Council, National Health and Medical Research Council …
The kynurenine pathway in chronic diseases: a compensatory mechanism or a driving force?
N Joisten, JL Ruas, N Braidy, GJ Guillemin, P Zimmer
Trends in Molecular Medicine 27 (10), 946-954, 2021
Mandates: National Health and Medical Research Council, Australia, Swedish Research …
Detection of the suspected neurotoxin β-methylamino-l-alanine (BMAA) in cyanobacterial blooms from multiple water bodies in Eastern Australia
BJ Main, LC Bowling, MP Padula, DP Bishop, SM Mitrovic, GJ Guillemin, ...
Harmful Algae 74, 10-18, 2018
Mandates: Australian Research Council
Microbiota alterations in Alzheimer’s disease: involvement of the kynurenine pathway and inflammation
ML Garcez, KR Jacobs, GJ Guillemin
Neurotoxicity research 36, 424-436, 2019
Mandates: Australian Research Council, National Health and Medical Research Council …
Involvement of quinolinic acid in the neuropathogenesis of amyotrophic lateral sclerosis
JM Lee, V Tan, D Lovejoy, N Braidy, DB Rowe, BJ Brew, GJ Guillemin
Neuropharmacology 112, 346-364, 2017
Mandates: Australian Research Council, National Health and Medical Research Council …
Kynurenine 3-monooxygenase activity in human primary neurons and effect on cellular bioenergetics identifies new neurotoxic mechanisms
G Castellano-Gonzalez, KR Jacobs, E Don, NJ Cole, S Adams, CK Lim, ...
Neurotoxicity Research 35, 530-541, 2019
Mandates: Australian Research Council, National Health and Medical Research Council …
Recent advances in clinical trials targeting the kynurenine pathway
AS Pires, G Sundaram, B Heng, S Krishnamurthy, BJ Brew, GJ Guillemin
Pharmacology & Therapeutics 236, 108055, 2022
Mandates: National Health and Medical Research Council, Australia
Optimisation of LRRK2 inhibitors and assessment of functional efficacy in cell-based models of neuroinflammation
L Munoz, ME Kavanagh, AF Phoa, B Heng, N Dzamko, EJ Chen, ...
European Journal of Medicinal Chemistry 95, 29-34, 2015
Mandates: Australian Research Council, National Health and Medical Research Council …
Alpha-synuclein transmission and mitochondrial toxicity in primary human foetal enteric neurons in vitro
N Braidy, WP Gai, YH Xu, P Sachdev, GJ Guillemin, XM Jiang, ...
Neurotoxicity Research 25, 170-182, 2014
Mandates: National Health and Medical Research Council, Australia
Current and emerging applications of saccharide-modified chitosan: a critical review
HKS Panahi, M Dehhaghi, H Amiri, GJ Guillemin, VK Gupta, A Rajaei, ...
Biotechnology advances 66, 108172, 2023
Mandates: National Natural Science Foundation of China
Myxobacterial natural products: An under-valued source of products for drug discovery for neurological disorders
M Dehhaghi, F Mohammadipanah, GJ Guillemin
Neurotoxicology 66, 195-203, 2018
Mandates: Australian Research Council
Telmisartan ameliorates astroglial and dopaminergic functions in a mouse model of chronic parkinsonism
S Sekar, S Mani, B Rajamani, T Manivasagam, AJ Thenmozhi, A Bhat, ...
Neurotoxicity Research 34, 597-612, 2018
Mandates: Department of Science & Technology, India
Toward a neuroprotective shift: Eight weeks of high intensity interval training reduces the neurotoxic kynurenine activity concurrently to impulsivity in emotionally impulsive …
F Javelle, W Bloch, A Knoop, GJ Guillemin, P Zimmer
Brain, Behavior, and Immunity 96, 7-17, 2021
Mandates: National Health and Medical Research Council, Australia
Kynurenines, gender and neuroinflammation; showcase schizophrenia
J De Bie, CK Lim, GJ Guillemin
Neurotoxicity research 30, 285-294, 2016
Mandates: Australian Research Council, National Health and Medical Research Council …
Protective effects of myxobacterial extracts on hydrogen peroxide-induced toxicity on human primary astrocytes
M Dehhaghi, V Tan, B Heng, F Mohammadipanah, GJ Guillemin
Neuroscience 399, 1-11, 2019
Mandates: Australian Research Council, National Health and Medical Research Council …
Characterisation of the kynurenine pathway in skin‐derived fibroblasts and keratinocytes
D Sheipouri, R Grant, S Bustamante, D Lovejoy, GJ Guillemin, N Braidy
Journal of cellular biochemistry 116 (6), 903-922, 2015
Mandates: National Health and Medical Research Council, Australia
Publication and funding information is determined automatically by a computer program